Clinical Trial

Genetic Testing for Men With Metastatic Prostate Cancer (GENTleMEN)

Investigator
Complete title:
GENTleMEN: GENetic Testing for MEN with metastatic prostate cancer
Trial phase:
Phase N/A
Study ID:
NCT03503097
Local study ID:
9831
Summary:
This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns about genetic testing, to determine if this is an acceptable way to deliver testing and to potentially help guide the participant's treatment. Neither treatment nor any decisions related to treatment will take place on this study, but researchers will share each participant's genetic testing results with that participant.
Trial keywords:
Prostate Cancer, Solid Tumors, Urogenital Neoplasms, Genital Neoplasms, Male, BRCA 1/2
Enrollment status:
Recruiting
Trial eligibility
** For Eligibility information, please click on the "Look up trial at NIH" link above **
Other eligibility criteria may apply.
Trial exclusions
Other exclusion criteria may apply.
Learn more

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Contact us
GENTleMEN Study, Study Line
phone 877/606-4368
phone 1-800-606-7800
Toll-free